Chariyawan Charalsawadi

Dr. Chariyawan Charalsawadi

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in International Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
CCChariyawan Charalsawadi
Chariyawan Charalsawadi
JWJuthamas Wirojanan
Juthamas Wirojanan
SJSomchit Jaruratanasirikul
Somchit Jaruratanasirikul
NRNichara Ruangdaraganon
Nichara Ruangdaraganon
AGAlan Geater
Alan Geater
PLPornprot Limprasert
Pornprot Limprasert
Background.Clinical characteristics of fragile X syndrome (FXS) have been well documented in Caucasians, whereas in Asians they have rarely been described. Those that have been conducted used small cohorts that utilized DNA for diagnosis and larger cohorts that utilized cytogenetics for diagnosis. This study is to describe clinical characteristics of FXS in a large cohort of Thai patients diagnosed by standard molecular methods.Methods.Seventy-seven index cases and 46 affected relatives diagnosed with FXS were recruited into the study. To determine frequencies of common characteristics of FXS in prepubertal boys, we reviewed 56 unrelated cases aged between 18 and 146 months. To list rare medical problems, we reviewed 75 cases aged between 8 months to 71 years old, including 53 index cases and 22 affected relatives. In addition, we selected 16 clinical studies from various ethnicities for comparison with our findings.Results.In prepubertal boys with FXS, attention deficit and/or hyperactivity, prominent ears, macroorchidism, and elongated face were observed in 96%, 80%, 53%, and 48% of patients, respectively, whereas recognizable X-linked inheritance presented in 11% of patients. IQ scores ranged between 30 and 64 (mean ± SD =43±9,n=25). We observed clinical findings that rarely or have never been reported, for example, medulloblastoma and tetralogy of Fallot.Conclusion.Attention deficit and/or hyperactivity and prominent ear are the most common behavioral and physical features in prepubertal boys with FXS, respectively. There are differences in frequencies of clinical characteristics observed between ethnicities; however, it is difficult to draw a solid conclusion due to different recruitment criteria and sample sizes within each study.

16 October 2016 in Genetics Research International
Verified
Journal Article
Open access
PDF file
CCChariyawan Charalsawadi
Chariyawan Charalsawadi
JKJariya Khayman
Jariya Khayman
VPVerayuth Praphanphoj
Verayuth Praphanphoj
PLPornprot Limprasert
Pornprot Limprasert
We utilized fluorescence in situ hybridization (FISH) to screen for subtelomeric rearrangements in 82 Thai patients with unexplained intellectual disability (ID) and detected subtelomeric rearrangements in 5 patients. Here, we reported on a patient with der(20)t(X;20)(p22.3;q13.3) and a patient with der(3)t(X;3)(p22.3;p26.3). These rearrangements have never been described elsewhere. We also reported on a patient with der(10)t(7;10)(p22.3;q26.3), of which the same rearrangement had been reported in one literature. Well-recognized syndromes were detected in two separated patients, including 4p deletion syndrome and 1p36 deletion syndrome. All patients with subtelomeric rearrangements had both ID and multiple congenital anomalies (MCA) and/or dysmorphic features (DF), except the one with der(20)t(X;20), who had ID alone. By using FISH, the detection rate of subtelomeric rearrangements in patients with both ID and MCA/DF was 8.5%, compared to 2.9% of patients with only ID. Literature review found 28 studies on the detection of subtelomeric rearrangements by FISH in patients with ID. Combining data from these studies and our study, 15,591 patients were examined and 473 patients with subtelomeric rearrangements were determined. The frequency of subtelomeric rearrangements detected by FISH in patients with ID was 3%. Terminal deletions were found in 47.7%, while unbalanced derivative chromosomes were found in 47.9% of the rearrangements.

1 January 2023 in Translational Pediatrics
Verified
Journal Article
Open access
PDF file
NNNarongsak Nakwan
Narongsak Nakwan
PKPunna Kunhapan
Punna Kunhapan
TCTassamonwan Chaiyasung
Tassamonwan Chaiyasung
NSNusara Satproedprai
Nusara Satproedprai
KSKamonnut Singkhamanan
Kamonnut Singkhamanan
CCChariyawan Charalsawadi
Chariyawan Charalsawadi
Background: There is known to be significant genetic involvement in persistent pulmonary hypertension of the newborn (PPHN), but to date there is not a clear understanding of this situation, and clarifying that involvement would be of considerable assistance in devising effective treatments for the disease. This case-control study was undertaken to search for genetic variants associated with PPHN in the Thai population using a genome-wide association study (GWAS). Methods: A 659,184 single nucleotide polymorphisms from 387 participants (54 PPHN cases and 333 healthy participants) were genotyped across the human genome using an Illumina Asian Screening Array-24 v1.0 BeadChip Array. After quality control, we obtained 443,063 autosomal SNPs for the GWAS analysis. The FaST-LMM and R packages were used for all statistical analyses. Results: For the case-control analysis, the genomic inflation factor (λ) was 1.016, rs149768622 T>C in the first intron of WWC2 gene showed the strongest association with a P value of 3.76E-08 and odds ratio (OR) of 13.24 (95% CI: 3.91–44.78). The variants at the LOC102723906/LOC105377599, CADM4, GPM6A, CIT, RIMBP2, LOC105374510, LOC105375193, PTPRN2, CDK14, and LCORL loci showed suggestive evidence of associations with PPHN (P<1E-05). Conclusions: This GWAS found that rs149768622 T>C in the WWC2 gene was possibly associated with PPHN. However, replication and functional studies are needed to validate this association and further explore the role(s) of the WWC2 gene in PPHN.

18 June 2024 in Clinical and Translational Science
Verified
Journal Article
Open access
KJKanoot Jaruthamsophon
Kanoot Jaruthamsophon
PSPornsiri Sangmanee
Pornsiri Sangmanee
OPOradawan Plong-on
Oradawan Plong-on
CCChariyawan Charalsawadi
Chariyawan Charalsawadi
CSCHONLAPHAT Sukasem
CHONLAPHAT Sukasem
Areerat HnoonualAreerat Hnoonual
Areerat Hnoonual
Genetic screening for HLA‐B*15:02 before prescribing carbamazepine is standard practice to prevent severe cutaneous adverse reactions in Asian populations. These reactions are associated not only with this allele but also with closely related HLA‐B75 serotype markers—HLA‐B*15:11 and HLA‐B*15:21—which are prevalent in several Asian countries. However, a reliable method for identifying HLA‐B75 serotype markers is still not available. We developed an in‐house quantitative PCR (qPCR) for HLA‐B75 screening and validated it using 303 anonymized DNA samples. Due to inadequate quality control, the qPCR results for 11 samples were excluded. We analyzed the sensitivity and specificity of the test using 93 HLA‐typed samples. The concordance between the qPCR method and an established screening method was assessed using 199 HLA‐screened samples tested for HLA‐B*15:02 at Songklanagarind Hospital, Songkhla, Thailand. All discordant results were confirmed by Sanger sequencing. The qPCR method demonstrated a sensitivity of 100% (95% confidence interval = 83.16%–100.00%) and a specificity of 100% (95% confidence interval = 95.07%–100.00%). Concordance analysis revealed a 96.5% agreement between methods (192/199; 44 positive and 148 negative results). All discordant results were due to HLA‐B75 markers not being HLA‐B*15:02 (two samples with HLA‐B*15:11 and five samples with HLA‐B*15:21). In conclusion, this qPCR method could be useful for identifying HLA‐B75 carriers at risk of carbamazepine‐induced reactions in Asian populations where carriers of HLA‐B*15:02, HLA‐B*15:11, or HLA‐B*15:21 are common.

20 October 2021 in Jornal de Pediatria
Verified
Journal Article
Open access
NNNarongsak Nakwan
Narongsak Nakwan
SMSurakameth Mahasirimongkol
Surakameth Mahasirimongkol
NSNusara Satproedprai
Nusara Satproedprai
TCTassamonwan Chaiyasung
Tassamonwan Chaiyasung
PKPunna Kunhapan
Punna Kunhapan
CCChariyawan Charalsawadi
Chariyawan Charalsawadi
To explore possible genes related to the development of persistent pulmonary hypertension of the newborn (PPHN). The authors identified 285 single nucleotide polymorphisms (SNPs) of 11 candidate genes (BMPR2, EPAS1, PDE3A, VEGFA, ENG, NOTCH3, SOD3, CPS1, ABCA3, ACVRL1, and SMAD9), using an Illumina Asian Screening Array-24 v1.0 BeadChip Array. The FastLmmC and R package was used for statistical analyses. The chi-square test and Cochrane-Armitage trend test were used to compare the allele and genotype frequencies between the groups and to test the genetic models, respectively. A total of 45 PPHN infants and 294 control subjects were analyzed. The most common cause of PPHN was meconium aspiration syndrome. Among the 285 SNPs, 17 SNPs from 6 candidate genes (BMPR2, EPAS1, PDE3A, VEGFA, ENG, and NOTCH3) were significantly associated with PPHN (P < 0.05). After using the Bonferroni correction (P < 0.00018), only the rs17034984 SNP located in intron 1 of the EPAS1 gene remained significantly different between the PPHN and control subjects (P = 0.00014). The frequency of the TC/TT genotype of rs17034984 in the gene with the dominant model was significant in the patients with PPHN (OR = 5.38, 95% CI: 2.15–13.49). The T allele frequency of rs17034984 in the gene showed a significant difference compared with the control subjects (OR = 4.89, 95% CI: 2.03–11.82). The present study suggests that the rs17034984 variant of EPAS1 gene is associated with PPHN.

Verified
Journal Article
Open access
PDF file
Areerat HnoonualAreerat Hnoonual
Areerat Hnoonual
OPOradawan Plong-on
Oradawan Plong-on
DTDuangkamol Tangviriyapaiboon
Duangkamol Tangviriyapaiboon
CCChariyawan Charalsawadi
Chariyawan Charalsawadi
PLPornprot Limprasert
Pornprot Limprasert
Fragile X syndrome (FXS) is the most common form of X-linked intellectual disability (ID). This study aimed to share 30 years of experience in diagnosing FXS and determine its frequency in Thailand. We retrospectively reviewed 1480 unrelated patients (1390 males and 90 females) with ID, developmental delay, or autism spectrum disorder, or individuals referred for FXS DNA testing at Songklanagarind Hospital, Thailand, over a 30-year period. The samples were analyzed using cytogenetic methods, PCR-based techniques, and/or Southern blot analysis. Full mutations (>200 CGG repeats) were identified in 100 males (7.2%) and three females (3.3%). An intermediate allele was detected in one male, while no premutation was found in the index cases. Two males were suspected to have FMR1 gene deletions. Twelve families underwent prenatal testing during this study. Most families undergoing prenatal FXS diagnosis involved mothers who were premutation carriers and had given birth to children affected by FXS. This study represents the largest series of molecular genetic FXS testing cases reported in Thailand. The frequency of FXS identified in different cohorts of Thai patients across various periods was approximately 7%. This study enhances public awareness of at-risk populations and highlights the importance of prenatal testing and genetic counseling for vulnerable families.